SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-169820
Filing Date
2023-06-20
Accepted
2023-06-20 10:18:56
Documents
8
Period of Report
2023-06-20

Document Format Files

Seq Description Document Type Size
1 6-K d511072d6k.htm 6-K 11427
2 EX-99.1 d511072dex991.htm EX-99.1 29556
3 EX-99.2 d511072dex992.htm EX-99.2 16594
4 EX-99.3 d511072dex993.htm EX-99.3 6859
5 EX-99.4 d511072dex994.htm EX-99.4 16277
6 GRAPHIC g511072g0619180315482.jpg GRAPHIC 2601
7 GRAPHIC g511072g0620144641718.jpg GRAPHIC 2512
8 GRAPHIC g511072g40o45.jpg GRAPHIC 1337
  Complete submission text file 0001193125-23-169820.txt   91223
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 231023808
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences